HomeAll ContractsContract
COVID-19:SUPPLEMENTAL WORK-SARS-COV-2 - PRECLINICAL WORK
Total Committed
$1.5M
Product or Service Description
Biomedical R&D
Total Potential Value
$6.95M
Contracting Agency
Effective Date
Jan. 30, 2017
Funding Department
NATIONAL INSTITUTES OF HEALTH NIAID
Type
Cost plus fixed fee
Solicitation Procedure
Negotiated proposal/quote
Extent Competed
Full and open competition

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Vendor Description Signed Reason for Change Amount Committed
CHRYSALIS BIOTHERAPEUTICS, INC. A NOVEL NUCLEAR COUNTERMEASURE TARGETING ENDOTHELIAL CELLS AND STEM CELLSTO COMBAT ARS AND DELAYED MULTIPLE ORGAN DYSFUNCTION March 26, 2021 Other Administrative Action $0
CHRYSALIS BIOTHERAPEUTICS, INC. SUPPLEMENTAL WORK - SARS-COV-2 PRECLINICAL WORK Aug. 10, 2020 Other Administrative Action $0
CHRYSALIS BIOTHERAPEUTICS, INC. SUPPLEMENTAL WORK-SARS-COV-2 OPTION - AIM 5 July 28, 2020 Supplemental Agreement For Work Within Scope $587,995
CHRYSALIS BIOTHERAPEUTICS, INC. COVID-19:SUPPLEMENTAL WORK-SARS-COV-2 - PRECLINICAL WORK June 5, 2020 Other Administrative Action $912,157
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.
Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page